Large-scale study finds vitamin supports lung function as well as bone health

27-03-2013

Maintaining adequate levels of vitamin D can help people breathe better and may even protect against tuberculosis (TB), according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The study of more than 10,000 Korean ...

more

GLOW2 study shows NVA237 provides superior 24-hour bronchodilation to placebo (p<0.001) with comparable efficacy to open-label tiotropium at 12 weeks

06-07-2011

Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237 (glycopyrronium bromide) 50 mcg significantly improved lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) relative to placebo (pFurther efficacy and safety results ...

more

Phase III studies show once-daily Onbrez Breezhaler plus tiotropium improved lung function (measured by trough FEV1) by up to 230 mL from baseline

18-05-2011

Results of two Phase III studies show that once-daily Onbrez® Breezhaler® (indacaterol) plus tiotropium produced a significantly greater improvement in lung function than tiotropium alone in patients with chronic obstructive pulmonary disease (COPD), supporting current treatment guidelines ...

more

08-11-2010

bitop AG announced the inclusion of the first patient into a clinical trial on the Ectoin inhalation solution in patients with inflammation and airway obstruction. The present clinical study is a single-center efficacy and feasibility study involving patients with inflammation and airway ...

more

24-09-2010

GlaxoSmithKline Plc (GSK) and Theravance, Inc. announced results from a Phase II safety and efficacy study for developmental combination treatment Relovair in chronic obstructive pulmonary disorder (COPD). Relovair is an investigational drug which combines fluticasone furoate (FF; an ...

more

02-08-2010

Researchers at Carnegie Mellon University have developed a new fluorescent biosensor that could aid in the development of an important class of drugs that target a crucial class of proteins called G protein-coupled receptors (GPCRs). "Drugs that target GPCRs make up approximately 30 percent ...

more

14-06-2010

Revotar Biopharmaceuticals AG announced the start of a Phase II study to evaluate the safety and efficacy of inhaled Bimosiamose, a pan-selectin antagonist, for the treatment of patients with chronic obstructive pulmonary disease (COPD). The trial is designed as a double-blind, placebo ...

more

CT scans can detect differences in lung blood flow patterns, which identify smokers most at risk of emphysema

08-04-2010

Using CT scans to measure blood flow in the lungs of people who smoke may offer a way to identify which smokers are most at risk of emphysema before the disease damages and eventually destroys areas of the lungs, according to a University of Iowa study. The study found that smokers who have ...

more

06-04-2010

A team of Swedish and American scientists has shown for the first time that carbon nanotubes can be broken down by an enzyme – myeloperoxidase (MPO) – found in white blood cells. Their discoveries are presented in Nature Nanotechnology and contradict what was previously believed, that carbon ...

more

New genetics study by consortium led by universities of Leicester and Nottingham

15-12-2009

Scientists have discovered five genetic variants that are associated with the health of the human lung. The research by an international consortium of 96 scientists from 63 centres in Europe and Australia sheds new light on the molecular basis of lung diseases. The new findings provide hope ...

more